Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons

Hung Li Wang, Cai Ying He, An Hsun Chou, Tu Hsueh Yeh, Ying Ling Chen, Allen Hon Lun Li

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Our recent study indicated that polyglutamine-expanded ataxin-7-Q75 induced apoptotic death of cultured cerebellar neurons by downregulating Bcl-xL expression and activating mitochondrial apoptotic cascade. Mutant polyglutamine-expanded proteins are believed to impair the proteolytic function of ubiquitin-proteasome system by sequestering components of proteasomes. Proteasome degradation of IκBα permits nuclear translocation of NF-κB and is required for continuous NF-κB activity, which supports the survival of cultured cerebellar neurons by inducing Bcl-xL expression. Thus, we tested the hypothesis that mutant ataxin-7-Q75 causes proteasome dysfunction and impairs NF-κB activity, leading to reduced Bcl-xL expression, caspase activation and cerebellar neuronal death. EMSA assays indicate that DNA-binding activity of NF-κB was significantly decreased in cerebellar neurons expressing ataxin-7-Q75. Similar to mutant ataxin-7-Q75, NF-κB inhibitor APEQ induced cerebellar neuronal death by decreasing Bcl-xL expression and activating caspase-9. Mutant ataxin-7-Q75 inhibited the proteolytic activity of proteasomes in cerebellar neurons. Proteasome inhibitor MG132 also caused cerebellar neuronal death by decreasing Bcl-xL expression and activating caspase-9. Both ataxin-7-Q75 and MG132 caused the cytosolic accumulation of IκBα in cerebellar neurons. Mutant ataxin-7-Q75 or MG132 increased the cytosolic level of NF-κB p65 and decreased the nuclear NF-κB p65 level. Our study provides the evidence that polyglutamine-expanded ataxin-7-Q75 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons.

Original languageEnglish
Pages (from-to)573-581
Number of pages9
JournalCellular Signalling
Volume19
Issue number3
DOIs
Publication statusPublished - Mar 2007
Externally publishedYes

Fingerprint

Proteasome Endopeptidase Complex
Neurons
Caspase 9
Proteasome Inhibitors
Ataxin-7
polyglutamine
Caspases
Ubiquitin
Down-Regulation
DNA
benzyloxycarbonylleucyl-leucyl-leucine aldehyde

Keywords

  • Ataxin-7
  • Cerebellum
  • NF-κB
  • Polyglutamine-expanded ataxin-7
  • Proteasome
  • Spinocerebellar ataxia type 7

ASJC Scopus subject areas

  • Cell Biology

Cite this

Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons. / Wang, Hung Li; He, Cai Ying; Chou, An Hsun; Yeh, Tu Hsueh; Chen, Ying Ling; Li, Allen Hon Lun.

In: Cellular Signalling, Vol. 19, No. 3, 03.2007, p. 573-581.

Research output: Contribution to journalArticle

@article{a479b2fe13504cd9925ae7e75b62f01d,
title = "Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons",
abstract = "Our recent study indicated that polyglutamine-expanded ataxin-7-Q75 induced apoptotic death of cultured cerebellar neurons by downregulating Bcl-xL expression and activating mitochondrial apoptotic cascade. Mutant polyglutamine-expanded proteins are believed to impair the proteolytic function of ubiquitin-proteasome system by sequestering components of proteasomes. Proteasome degradation of IκBα permits nuclear translocation of NF-κB and is required for continuous NF-κB activity, which supports the survival of cultured cerebellar neurons by inducing Bcl-xL expression. Thus, we tested the hypothesis that mutant ataxin-7-Q75 causes proteasome dysfunction and impairs NF-κB activity, leading to reduced Bcl-xL expression, caspase activation and cerebellar neuronal death. EMSA assays indicate that DNA-binding activity of NF-κB was significantly decreased in cerebellar neurons expressing ataxin-7-Q75. Similar to mutant ataxin-7-Q75, NF-κB inhibitor APEQ induced cerebellar neuronal death by decreasing Bcl-xL expression and activating caspase-9. Mutant ataxin-7-Q75 inhibited the proteolytic activity of proteasomes in cerebellar neurons. Proteasome inhibitor MG132 also caused cerebellar neuronal death by decreasing Bcl-xL expression and activating caspase-9. Both ataxin-7-Q75 and MG132 caused the cytosolic accumulation of IκBα in cerebellar neurons. Mutant ataxin-7-Q75 or MG132 increased the cytosolic level of NF-κB p65 and decreased the nuclear NF-κB p65 level. Our study provides the evidence that polyglutamine-expanded ataxin-7-Q75 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons.",
keywords = "Ataxin-7, Cerebellum, NF-κB, Polyglutamine-expanded ataxin-7, Proteasome, Spinocerebellar ataxia type 7",
author = "Wang, {Hung Li} and He, {Cai Ying} and Chou, {An Hsun} and Yeh, {Tu Hsueh} and Chen, {Ying Ling} and Li, {Allen Hon Lun}",
year = "2007",
month = "3",
doi = "10.1016/j.cellsig.2006.08.006",
language = "English",
volume = "19",
pages = "573--581",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons

AU - Wang, Hung Li

AU - He, Cai Ying

AU - Chou, An Hsun

AU - Yeh, Tu Hsueh

AU - Chen, Ying Ling

AU - Li, Allen Hon Lun

PY - 2007/3

Y1 - 2007/3

N2 - Our recent study indicated that polyglutamine-expanded ataxin-7-Q75 induced apoptotic death of cultured cerebellar neurons by downregulating Bcl-xL expression and activating mitochondrial apoptotic cascade. Mutant polyglutamine-expanded proteins are believed to impair the proteolytic function of ubiquitin-proteasome system by sequestering components of proteasomes. Proteasome degradation of IκBα permits nuclear translocation of NF-κB and is required for continuous NF-κB activity, which supports the survival of cultured cerebellar neurons by inducing Bcl-xL expression. Thus, we tested the hypothesis that mutant ataxin-7-Q75 causes proteasome dysfunction and impairs NF-κB activity, leading to reduced Bcl-xL expression, caspase activation and cerebellar neuronal death. EMSA assays indicate that DNA-binding activity of NF-κB was significantly decreased in cerebellar neurons expressing ataxin-7-Q75. Similar to mutant ataxin-7-Q75, NF-κB inhibitor APEQ induced cerebellar neuronal death by decreasing Bcl-xL expression and activating caspase-9. Mutant ataxin-7-Q75 inhibited the proteolytic activity of proteasomes in cerebellar neurons. Proteasome inhibitor MG132 also caused cerebellar neuronal death by decreasing Bcl-xL expression and activating caspase-9. Both ataxin-7-Q75 and MG132 caused the cytosolic accumulation of IκBα in cerebellar neurons. Mutant ataxin-7-Q75 or MG132 increased the cytosolic level of NF-κB p65 and decreased the nuclear NF-κB p65 level. Our study provides the evidence that polyglutamine-expanded ataxin-7-Q75 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons.

AB - Our recent study indicated that polyglutamine-expanded ataxin-7-Q75 induced apoptotic death of cultured cerebellar neurons by downregulating Bcl-xL expression and activating mitochondrial apoptotic cascade. Mutant polyglutamine-expanded proteins are believed to impair the proteolytic function of ubiquitin-proteasome system by sequestering components of proteasomes. Proteasome degradation of IκBα permits nuclear translocation of NF-κB and is required for continuous NF-κB activity, which supports the survival of cultured cerebellar neurons by inducing Bcl-xL expression. Thus, we tested the hypothesis that mutant ataxin-7-Q75 causes proteasome dysfunction and impairs NF-κB activity, leading to reduced Bcl-xL expression, caspase activation and cerebellar neuronal death. EMSA assays indicate that DNA-binding activity of NF-κB was significantly decreased in cerebellar neurons expressing ataxin-7-Q75. Similar to mutant ataxin-7-Q75, NF-κB inhibitor APEQ induced cerebellar neuronal death by decreasing Bcl-xL expression and activating caspase-9. Mutant ataxin-7-Q75 inhibited the proteolytic activity of proteasomes in cerebellar neurons. Proteasome inhibitor MG132 also caused cerebellar neuronal death by decreasing Bcl-xL expression and activating caspase-9. Both ataxin-7-Q75 and MG132 caused the cytosolic accumulation of IκBα in cerebellar neurons. Mutant ataxin-7-Q75 or MG132 increased the cytosolic level of NF-κB p65 and decreased the nuclear NF-κB p65 level. Our study provides the evidence that polyglutamine-expanded ataxin-7-Q75 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons.

KW - Ataxin-7

KW - Cerebellum

KW - NF-κB

KW - Polyglutamine-expanded ataxin-7

KW - Proteasome

KW - Spinocerebellar ataxia type 7

UR - http://www.scopus.com/inward/record.url?scp=33846220180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846220180&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2006.08.006

DO - 10.1016/j.cellsig.2006.08.006

M3 - Article

C2 - 17005371

AN - SCOPUS:33846220180

VL - 19

SP - 573

EP - 581

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 3

ER -